NTRK fusion-positive cancers and TRK inhibitor therapy
Emiliano CoccoHuman Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, NY, USAMaurizio ScaltritiDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USAAlexander DrilonDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. [email protected]
2018en
ABI
Аннотация
Аннотация мавжуд эмас.
Идентификаторлар
Иқтибослар ва манбалар
2 та иқтибос0 та фойдаланилган манба